Skip to content

Relationship Between Red Blood Cell Lifespan and Blood Glucose and Glycosylated Hemoglobin in Type 2 Diabetes Mellitus Patients before and after treatment

Relationship Between Red Blood Cell Lifespan and Blood Glucose and Glycosylated Hemoglobin in Type 2 Diabetes Mellitus Patients before and after treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018975
Enrollment
Unknown
Registered
2018-10-19
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

one:take hypoglycemic agents orally
two:inject insulin
three:take hypoglycemic agents orally and inject insulin

Sponsors

Nanshan Affiliated Hospital of Shenzhen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: All type 2 diabetic patients meet the standard of the diagnosis and classification of type 2 diabetic, which made by the WHO in 1999. Aged between 18 and 65 years, have lived in the area at least 5 years, HBA1C = 7%, FPG =7.0mmol/l and/or 2hPG =11.1mmol/l,without severe acute or chronic complications of diabetes.

Exclusion criteria

Exclusion criteria: The exclusion criteria included having such diseases in the last 6 months: 1. Hematological diseases; 2. Cancer and other chronic wasting diseases such as tuberculosis and thyroidism; 3. Infectious diseases; 4. Liver disease or transaminases increased for more than 3 times; 5. Kidney disease (creatinine=1.5mg/dl) or rheumatoid arthritis; 6. Valve replacement, cardiac function class III or above according to the NYHA; 7. Bleeding history, blood donation or blood transfusion within 4 months; 8. Smokers; 9. Impaired pulmonary function; 10. Pregnancy; 11. Application of drug which could affect the lifespan of RBC, such as ribavirin, barbital or phenobarbitone sodium. Women patients should avoid the menstrual period when monitoring RBC lifespan.

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose;glycosylated hemoglobin;red blood cells count;Red blood cell deformability;hematocrit;triglyceride;total cholesterol;high density lipoprotein choleste;low density lipoprotein choleste;alanine aminotransferase;aspartate aminotransferase;serum creatinine (Cr);hemoglobin;blood sugar;fructosamine;Urinary protein;

Countries

China

Contacts

Public ContactZhenhe Huang

Nanshan Affiliated Hospital of Shenzhen University

hzh932@126.com+86 13802235381

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026